- Home
- ANIX vs WAI Comparison
ANIX vs WAI Comparison
Compare ANIX & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- WAI
- Stock Information
- Founded
- ANIX 1982
- WAI 2018
- Country
- ANIX United States
- WAI China
- Employees
- ANIX N/A
- WAI N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- WAI
- Sector
- ANIX Health Care
- WAI
- Exchange
- ANIX Nasdaq
- WAI NYSE
- Market Cap
- ANIX 82.7M
- WAI 87.8M
- IPO Year
- ANIX 1987
- WAI 2023
- Fundamental
- Price
- ANIX $2.41
- WAI $0.33
- Analyst Decision
- ANIX Strong Buy
- WAI
- Analyst Count
- ANIX 2
- WAI 0
- Target Price
- ANIX $8.50
- WAI N/A
- AVG Volume (30 Days)
- ANIX 121.1K
- WAI 82.4K
- Earning Date
- ANIX 01-10-2025
- WAI 02-21-2025
- Dividend Yield
- ANIX N/A
- WAI N/A
- EPS Growth
- ANIX N/A
- WAI N/A
- EPS
- ANIX N/A
- WAI N/A
- Revenue
- ANIX N/A
- WAI $3,989,698.00
- Revenue This Year
- ANIX N/A
- WAI N/A
- Revenue Next Year
- ANIX N/A
- WAI N/A
- P/E Ratio
- ANIX N/A
- WAI N/A
- Revenue Growth
- ANIX N/A
- WAI N/A
- 52 Week Low
- ANIX $2.07
- WAI $0.19
- 52 Week High
- ANIX $5.09
- WAI $1.75
- Technical
- Relative Strength Index (RSI)
- ANIX 44.08
- WAI N/A
- Support Level
- ANIX $2.07
- WAI N/A
- Resistance Level
- ANIX $2.69
- WAI N/A
- Average True Range (ATR)
- ANIX 0.19
- WAI 0.00
- MACD
- ANIX 0.03
- WAI 0.00
- Stochastic Oscillator
- ANIX 54.84
- WAI 0.00
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides a number of essential business services in China to young and emerging companies including corporate business training services, which mainly focus on advanced knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising, and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).